CARE
Price
$31.60
Change
-$0.96 (-2.95%)
Updated
Jul 13 closing price
Capitalization
701.84M
10 days until earnings call
Intraday BUY SELL Signals
FRME
Price
$43.30
Change
+$0.20 (+0.46%)
Updated
Jul 13 closing price
Capitalization
2.73B
9 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CARE vs FRME

CARE vs FRME Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
CARE vs. FRME commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CARE is a StrongBuy and FRME is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (CARE: $32.56 vs. FRME: $43.30)
Brand notoriety: CARE and FRME are both not notable
Both companies represent the Regional Banks industry
Current volume relative to the 65-day Moving Average: CARE: 36% vs. FRME: 82%
Market capitalization -- CARE: $701.84M vs. FRME: $2.73B
CARE [@Regional Banks] is valued at $701.84M. FRME’s [@Regional Banks] market capitalization is $2.73B. The market cap for tickers in the [@Regional Banks] industry ranges from $142.82B to $0. The average market capitalization across the [@Regional Banks] industry is $6.48B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CARE’s FA Score shows that 1 FA rating(s) are green whileFRME’s FA Score has 1 green FA rating(s).

  • CARE’s FA Score: 1 green, 4 red.
  • FRME’s FA Score: 1 green, 4 red.
According to our system of comparison, FRME is a better buy in the long-term than CARE.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CARE’s TA Score shows that 3 TA indicator(s) are bullish while FRME’s TA Score has 4 bullish TA indicator(s).

  • CARE’s TA Score: 3 bullish, 4 bearish.
  • FRME’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CARE is a better buy in the short-term than FRME.

Price Growth

CARE (@Regional Banks) experienced а -1.72% price change this week, while FRME (@Regional Banks) price change was -0.30% for the same time period.

The average weekly price growth across all stocks in the @Regional Banks industry was -0.53%. For the same industry, the average monthly price growth was +2.46%, and the average quarterly price growth was +15.28%.

Reported Earning Dates

CARE is expected to report earnings on Jul 23, 2026.

FRME is expected to report earnings on Jul 22, 2026.

Industries' Descriptions

@Regional Banks (-0.53% weekly)

Regional banks have a smaller reach than major banks, and cater mostly to one region of a country, such as a state or within a group of states. They offer services often similar – albeit with some limitations/smaller scale – compared to major banks. Taking deposits, making loans, mortgages, leases, credit cards , fund management, insurance and investment banking. SunTrust Banks, State Street Corp., M&T Bank Corp. are some examples of U.S. regional banks.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
FRME($2.73B) has a higher market cap than CARE($702M). FRME has higher P/E ratio than CARE: FRME (12.77) vs CARE (6.49). CARE YTD gains are higher at: 61.345 vs. FRME (17.703). FRME has more cash in the bank: 98.1M vs. CARE (36.9M). CARE has less debt than FRME: CARE (178M) vs FRME (1.39B). FRME has higher revenues than CARE: FRME (660M) vs CARE (219M).
CAREFRMECARE / FRME
Capitalization702M2.73B26%
EBITDAN/AN/A-
Gain YTD61.34517.703347%
P/E Ratio6.4912.7751%
Revenue219M660M33%
Total Cash36.9M98.1M38%
Total Debt178M1.39B13%
FUNDAMENTALS RATINGS
CARE vs FRME: Fundamental Ratings
CARE
FRME
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
28
Undervalued
PROFIT vs RISK RATING
1..100
1977
SMR RATING
1..100
3541
PRICE GROWTH RATING
1..100
3748
P/E GROWTH RATING
1..100
9541
SEASONALITY SCORE
1..100
5050

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

FRME's Valuation (28) in the Regional Banks industry is somewhat better than the same rating for CARE (67). This means that FRME’s stock grew somewhat faster than CARE’s over the last 12 months.

CARE's Profit vs Risk Rating (19) in the Regional Banks industry is somewhat better than the same rating for FRME (77). This means that CARE’s stock grew somewhat faster than FRME’s over the last 12 months.

CARE's SMR Rating (35) in the Regional Banks industry is in the same range as FRME (41). This means that CARE’s stock grew similarly to FRME’s over the last 12 months.

CARE's Price Growth Rating (37) in the Regional Banks industry is in the same range as FRME (48). This means that CARE’s stock grew similarly to FRME’s over the last 12 months.

FRME's P/E Growth Rating (41) in the Regional Banks industry is somewhat better than the same rating for CARE (95). This means that FRME’s stock grew somewhat faster than CARE’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
CAREFRME
RSI
ODDS (%)
Bearish Trend 4 days ago
67%
Bearish Trend 4 days ago
70%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
70%
Bearish Trend 4 days ago
61%
Momentum
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
64%
MACD
ODDS (%)
Bearish Trend 4 days ago
62%
Bearish Trend 4 days ago
56%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
61%
Bearish Trend 4 days ago
61%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
71%
Bullish Trend 4 days ago
48%
Advances
ODDS (%)
Bullish Trend 4 days ago
67%
Bullish Trend 4 days ago
59%
Declines
ODDS (%)
N/A
N/A
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
57%
Bearish Trend 4 days ago
76%
Aroon
ODDS (%)
Bullish Trend 4 days ago
66%
Bullish Trend 4 days ago
38%
View a ticker or compare two or three
Interact to see
Advertisement
CARE
Daily Signal:
Gain/Loss:
FRME
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
EVUS35.74N/A
N/A
iShares ESG Aware MSCI USA Value ETF
BSVO28.99N/A
N/A
EA Bridgeway Omni Small-Cap Value ETF
UNHG23.71N/A
N/A
Leverage Shares 2X Long UNH Daily ETF
BAMB25.80-0.08
-0.31%
Brookstone Intermediate Bond ETF
IMAY31.68-0.15
-0.47%
Innovator Intl Dev Pwr Bffr ETF - May

CARE and

Correlation & Price change

A.I.dvisor indicates that over the last year, CARE has been closely correlated with BY. These tickers have moved in lockstep 69% of the time. This A.I.-generated data suggests there is a high statistical probability that if CARE jumps, then BY could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CARE
1D Price
Change %
CARE100%
-2.95%
BY - CARE
69%
Closely correlated
+0.35%
GSBC - CARE
69%
Closely correlated
-0.12%
SRCE - CARE
69%
Closely correlated
+0.37%
EFSC - CARE
68%
Closely correlated
+0.81%
FRME - CARE
68%
Closely correlated
+0.46%
More